Novel insights into the role of aptamers in the fight against cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel insights into the role of aptamers in the fight against cancer
Authors
Keywords
Aptamer, Antibody, Cancer cell heterogeneity and plasticity, Targeted therapy, Immunotherapy, SELEX
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 145, Issue 4, Pages 797-810
Publisher
Springer Nature
Online
2019-03-04
DOI
10.1007/s00432-019-02882-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells
- (2019) Yasen Maimaitiyiming et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray
- (2018) Irawan Cosphiadi et al. Clinical Breast Cancer
- Molecular targeted therapy: treating cancer with specificity
- (2018) Yeuan Ting Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
- (2018) John D. Hainsworth et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers
- (2018) Christina Kratschmer et al. Molecular Therapy-Nucleic Acids
- Selection of metastatic breast cancer cell-specific aptamers for the capture of CTCs with a metastatic phenotype by Cell-SELEX
- (2018) Wan-Ming Li et al. Molecular Therapy-Nucleic Acids
- Overcoming Resistance of Human Non-Hodgkin’s Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors
- (2018) Antoni Torres-Collado et al. Cancers
- Application of aptamers for in vivo molecular imaging and theranostics
- (2018) Alix Bouvier-Müller et al. ADVANCED DRUG DELIVERY REVIEWS
- SELEX methods on the road to protein targeting with nucleic acid aptamers
- (2018) Payam Bayat et al. BIOCHIMIE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antiangiogenic Therapy in Colorectal Cancer
- (2018) Kabir Mody et al. CANCER JOURNAL
- PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
- (2018) Fatemeh K. Dermani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Human genomics projects and precision medicine
- (2017) F Carrasco-Ramiro et al. GENE THERAPY
- Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
- (2017) Carlos A. Ramos et al. JOURNAL OF CLINICAL INVESTIGATION
- Dimerization of Cell-Adhesion Molecules Can Increase Their Binding Strength
- (2017) Wenmao Huang et al. LANGMUIR
- Rituximab treatment of myasthenia gravis: A systematic review
- (2017) Rup Tandan et al. MUSCLE & NERVE
- Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
- (2017) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope
- (2017) Jonathan M. Lehman et al. Current Oncology Reports
- Oligonucleotide Hybridization Combined with Competitive Antibody Binding for the Truncation of a High-Affinity Aptamer
- (2017) Cong Quang Vu et al. ACS Combinatorial Science
- Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells
- (2017) Gang Zhou et al. Theranostics
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Self-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery
- (2016) Wenshan Li et al. ACS Applied Materials & Interfaces
- Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
- (2016) Yijuan Zhang et al. ACS Nano
- Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles
- (2016) Xiaozhou Fan et al. International Journal of Nanomedicine
- Application of aptamers in diagnostics, drug-delivery and imaging
- (2016) Chetan Chandola et al. JOURNAL OF BIOSCIENCES
- An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies
- (2016) Kyun Heo et al. JOURNAL OF CONTROLLED RELEASE
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
- (2016) A Michael Lincoff et al. LANCET
- Methods for Improving Aptamer Binding Affinity
- (2016) Hijiri Hasegawa et al. MOLECULES
- Improved Synthesis andIn VitroEvaluation of an Aptamer Ribosomal Toxin Conjugate
- (2016) Linsley Kelly et al. Nucleic Acid Therapeutics
- MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
- (2016) Mario Martínez Soldevilla et al. Oncotarget
- Aptamers: A Feasible Technology in Cancer Immunotherapy
- (2016) M. M. Soldevilla et al. Journal of Immunology Research
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- Therapeutic aptamers: developmental potential as anticancer drugs
- (2015) Ji Won Lee et al. BMB Reports
- Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase
- (2015) D Di Gioia et al. BRITISH JOURNAL OF CANCER
- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- Active Immunotherapy of Cancer
- (2015) Thinle Chodon et al. IMMUNOLOGICAL INVESTIGATIONS
- Cancer immunotherapy via nucleic acid aptamers
- (2015) Mostafa Khedri et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Aptamers: new arrows to target dendritic cells
- (2015) A. Ganji et al. JOURNAL OF DRUG TARGETING
- Selection of LNA-containing DNA aptamers against recombinant human CD73
- (2015) Ida C. Elle et al. Molecular BioSystems
- Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
- (2015) Abhisek Swaika et al. MOLECULAR IMMUNOLOGY
- Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
- (2015) Aaron Prodeus et al. Molecular Therapy-Nucleic Acids
- Just in Time-Selection: A Rapid Semiautomated SELEX of DNA Aptamers Using Magnetic Separation and BEAMing
- (2014) Tim Hünniger et al. ANALYTICAL CHEMISTRY
- Mini-Array of Multiple Tumor-associated Antigens (TAAs) in the Immunodiagnosis of Esophageal Cancer
- (2014) Jie-Jie Qin et al. Asian Pacific Journal of Cancer Prevention
- Improved Ligand Binding by Antibody–Aptamer Pincers
- (2014) Sungmuk Kang et al. BIOCONJUGATE CHEMISTRY
- Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans
- (2014) L. T. van Eijk et al. BLOOD
- Aptamers as Drug Delivery Vehicles
- (2014) Sven Kruspe et al. ChemMedChem
- Th1 cytokine-based immunotherapy for cancer
- (2014) Hong-Mei Xu Hepatobiliary & Pancreatic Diseases International
- Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor
- (2014) Shashi Gupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
- (2014) Andreas Herrmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia
- (2014) Hong-Hu Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
- (2014) A Roesch ONCOGENE
- Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer
- (2014) Weihong Liu et al. TUMOR BIOLOGY
- Radiogenomics: Using Genetics to Identify Cancer Patients at Risk for Development of Adverse Effects Following Radiotherapy
- (2014) S. L. Kerns et al. Cancer Discovery
- Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy
- (2014) Qiaoling Liu et al. NPG Asia Materials
- Specific and Sensitive Tumor Imaging Using Biostable Oligonucleotide Aptamer Probes
- (2014) Zihua Zeng et al. Theranostics
- Aptamers as Both Drugs and Drug-Carriers
- (2014) Md. Ashrafuzzaman Biomed Research International
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Identification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand
- (2014) Mst. Naznin Ara et al. Cancer Medicine
- A Cancer Cell-Activatable Aptamer-Reporter System for One-Step Assay of Circulating Tumor Cells
- (2014) Zihua Zeng et al. Molecular Therapy-Nucleic Acids
- Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture
- (2013) Yanling Song et al. ANALYTICAL CHEMISTRY
- Level of agreement among Latin American glaucoma subspecialists on the diagnosis and treatment of glaucoma: results of an online survey
- (2013) Daniel E. Grigera et al. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
- Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer
- (2013) Wenjin Xu et al. BIOMATERIALS
- Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer
- (2013) Parag Parekh et al. BIOMATERIALS
- Cancer Research Advocacy: Past, Present, and Future
- (2013) J. Perlmutter et al. CANCER RESEARCH
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics
- (2013) G. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating Tumor Cells
- (2013) V. Plaks et al. SCIENCE
- Update on current and future novel therapies for dry age-related macular degeneration
- (2013) Ella Leung et al. Expert Review of Clinical Pharmacology
- Dimeric DNA Aptamer Complexes for High-capacity–targeted Drug Delivery Using pH-sensitive Covalent Linkages
- (2013) Olcay Boyacioglu et al. Molecular Therapy-Nucleic Acids
- CD28 Aptamers as Powerful Immune Response Modulators
- (2013) Fernando Pastor et al. Molecular Therapy-Nucleic Acids
- In vivo SELEX for Identification of Brain-penetrating Aptamers
- (2013) Congsheng Cheng et al. Molecular Therapy-Nucleic Acids
- Targeted immunotherapy of cancer with CAR T cells: achievements and challenges
- (2012) Grazyna Lipowska-Bhalla et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells
- (2012) J. Cui et al. CANCER RESEARCH
- Self-Assembled Aptamer-Based Drug Carriers for Bispecific Cytotoxicity to Cancer Cells
- (2012) Guizhi Zhu et al. Chemistry-An Asian Journal
- A nanoscale drug delivery carrier using nucleic acid aptamers for extended release of therapeutic
- (2012) Padma Sundaram et al. Nanomedicine-Nanotechnology Biology and Medicine
- Development of a Novel DNA Aptamer Ligand Targeting to Primary Cultured Tumor Endothelial Cells by a Cell-Based SELEX Method
- (2012) Mst. Naznin Ara et al. PLoS One
- Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia
- (2012) Matthew Gissel et al. THROMBOSIS RESEARCH
- The circular dichroism and differential scanning calorimetry study of the properties of DNA aptamer dimers
- (2011) Slavomíra Poniková et al. BIOPHYSICAL CHEMISTRY
- Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application
- (2011) Sophia N. Karagiannis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse
- (2011) Anna Merlos-Suárez et al. Cell Stem Cell
- Chimeric aptamers in cancer cell-targeted drug delivery
- (2011) Jagat R. Kanwar et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Recent advances in the application of antibodies as therapeutics
- (2011) Roberta E Burden et al. Future Medicinal Chemistry
- Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
- (2011) Ronak Savla et al. JOURNAL OF CONTROLLED RELEASE
- Where Are All the Aptamers?
- (2010) Geoffrey S. Baird AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The Diagnosis and Treatment Decisions of Cancer Patients in Rural Western Australia
- (2010) Ruth McConigley et al. CANCER NURSING
- U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab
- (2010) S. J. Lemery et al. CLINICAL CANCER RESEARCH
- Antibody-aptamer functionalized fibre-optic biosensor for specific detection of Listeria monocytogenes from food
- (2010) S.H. Ohk et al. JOURNAL OF APPLIED MICROBIOLOGY
- Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment
- (2009) Jaume Capdevila et al. CANCER TREATMENT REVIEWS
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency
- (2009) Maximilian C. R. Buff et al. NUCLEIC ACIDS RESEARCH
- The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediatedex vivoplatelet function in acute myocardial infarction
- (2009) Alexander O. Spiel et al. PLATELETS
- Active and Passive Immunotherapy for Neurodegenerative Disorders
- (2008) David L. Brody et al. Annual Review of Neuroscience
- The History of Cancer Research: Introducing an AACR Centennial Series
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia
- (2008) S. Demko et al. ONCOLOGIST
- Improvement of Aptamer Affinity by Dimerization
- (2008) Hijiri Hasegawa et al. SENSORS
- Cell-Specific Internalization Study of an Aptamer from Whole Cell Selection
- (2007) Zeyu Xiao et al. CHEMISTRY-A EUROPEAN JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More